A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis
A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis. A Phase 2, Randomized, Double Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of PF-06826647 in Participants With Moderate to Severe Plaque Psoriasis.
Category & Conditions: Immune System Diseases and Conditions
Medicine: PF-06826647
ClinicalTrials.gov Identifier (NCT): NCT03895372
Protocol ID: C2501004
Open Plain Language Summary Result:
Click here